We are live on
!
Find out more
ED
Exane Derivatives Portfolio holdings
AUM
$174M
1-Year Est. Return
7.84%
This Fund
S&P 500
This Quarter
Est. Return
+12.78%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
–
AUM
$506M
AUM Growth
-$51.4M
(-9.2%)
Cap. Flow
-$43.2M
Cap. Flow
% of AUM
-8.54%
Top 10 Holdings %
Top 10 Hldgs %
27.96%
Holding
739
New
70
Increased
160
Reduced
252
Closed
106
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$11.6M |
| 2 |
iShares MSCI Philippines ETF
EPHE
|
+$9.69M |
| 3 |
iShares MSCI China ETF
MCHI
|
+$6.25M |
| 4 |
Eaton
ETN
|
+$4.48M |
| 5 |
Gilead Sciences
GILD
|
+$4.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Thailand ETF
THD
|
+$7.93M |
| 2 |
iShares MSCI Chile ETF
ECH
|
+$6.49M |
| 3 |
Boeing
BA
|
+$6.44M |
| 4 |
Linde
LIN
|
+$6.16M |
| 5 |
Chemours
CC
|
+$4.87M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Materials | 9.77% |
| 2 | Energy | 7.83% |
| 3 | Technology | 7.77% |
| 4 | Financials | 7.67% |
| 5 | Consumer Discretionary | 7.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Sarepta Therapeutics
SRPT
$1.68B
| $241K | 0.05% |
2,023
+285
| +16% | +$36.6K |
|
202
Banco Santander
SAN
$200B
| $238K | 0.05% |
53,760
-334,934
| -86% | -$1.53M |
|
203
Invesco QQQ Trust
QQQ
$449B
| $236K | 0.05% |
1,316
-154
| -10% | -$26.1K |
|
|
RTN
204
DELISTED
Raytheon Company
RTN
| $234K | 0.05% |
1,288
-4,843
| -79% | -$844K |
|
205
General Motors
GM
$78.7B
| $232K | 0.05% |
+6,266
| New | +$238K |
|
206
Newmont
NEM
$98.5B
| $230K | 0.05% |
+6,423
| New | +$218K |
|
207
Coca-Cola Europacific Partners
CCEP
$48.1B
| $228K | 0.05% |
4,407
-773
| -15% | -$36.7K |
|
208
MetLife
MET
$61.2B
| $224K | 0.04% |
5,256
-766
| -13% | -$33.9K |
|
|
APHA
209
DELISTED
Aphria Inc. Common Shares
APHA
| $222K | 0.04% |
+23,780
| New | +$209K |
|
210
ConocoPhillips
COP
$141B
| $220K | 0.04% |
3,304
-54,068
| -94% | -$3.64M |
|
211
Weibo
WB
$1.92B
| $219K | 0.04% |
3,536
+2,436
| +221% | +$151K |
|
212
Intel
INTC
$462B
| $214K | 0.04% |
3,991
-80,217
| -95% | -$4.07M |
|
213
Enbridge
ENB
$121B
| $211K | 0.04% |
5,834
| – | – |
|
214
Willis Towers Watson
WTW
$28.6B
| $209K | 0.04% |
1,189
-148
| -11% | -$24.6K |
|
215
Cigna
CI
$77B
| $207K | 0.04% |
1,287
+870
| +209% | +$159K |
|
216
iShares Floating Rate Bond ETF
FLOT
$10.2B
| $206K | 0.04% |
4,050
-321
| -7% | -$16.3K |
|
217
Global X Robotics & Artificial Intelligence ETF
BOTZ
$3.2B
| $199K | 0.04% |
9,900
| – | – |
|
218
Alphabet (Google) Class C
GOOG
$3.99T
| $194K | 0.04% |
3,300
-16,700
| -84% | -$937K |
|
219
Chevron
CVX
$378B
| $193K | 0.04% |
1,566
-10,364
| -87% | -$1.23M |
|
220
State Street
STT
$50.7B
| $190K | 0.04% |
2,884
+1,084
| +60% | +$75.1K |
|
|
K
221
DELISTED
Kellanova
K
| $189K | 0.04% |
3,510
+594
| +20% | +$31.7K |
|
222
Viatris
VTRS
$20.5B
| $187K | 0.04% |
6,588
-911
| -12% | -$26.6K |
|
223
Dropbox
DBX
$7.13B
| $184K | 0.04% |
8,424
+2,324
| +38% | +$54.1K |
|
224
Mattel
MAT
$4.3B
| $182K | 0.04% |
14,011
+44
| +0.3% | +$588 |
|
|
XLNX
225
DELISTED
Xilinx Inc
XLNX
| $181K | 0.04% |
1,428
-27,924
| -95% | -$3.14M |
|
Similar funds
PC
TWMP
LPWM
ACM
HWIS
LWM
EW
GDWAM
Exane Derivatives's Q1 2019 Portfolio in Review
As of Q1 2019, Exane Derivatives held 739 positions worth $506M, down 9.2% from $557M the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Exane Derivatives withdrew a net $43.2M in Q1 2019, closing 106 positions and reducing 252 holdings. Its most notable exit was Boeing, an estimated $6.44M position sold in full.
By sector, the portfolio is most concentrated in Materials at 9.8% of assets, down from 11% a quarter earlier, followed by Energy and Technology.
Against the trend, Exane Derivatives opened a new position in UBS Group worth $11.2M.
- Exane Derivatives's largest Q1 2019 buy was UBS Group: 919,334 shares worth $11.2M.
- Exane Derivatives added most to iShares MSCI Philippines ETF in Q1 2019, an estimated $9.69M increase.
- Exane Derivatives's biggest Q1 2019 reduction was iShares MSCI Thailand ETF, cutting an estimated $7.93M.
- Exane Derivatives fully exited Boeing in Q1 2019, selling an estimated $6.44M.
- Exane Derivatives's ten largest holdings make up 28% of its $506M portfolio in Q1 2019.
- Exane Derivatives opened 70 new positions and closed 106 in Q1 2019.
- Exane Derivatives's portfolio value fell 9.2% quarter-over-quarter to $506M.
Based on Exane Derivatives's 13F filing for Q1 2019, filed 24 Apr 2019.